4 studies on Igf 1r mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GH's ability to suppress mammary `TPH1` and thereby reduce local serotonin synthesis** adds a mechanistic layer that is entirely separate from the classical GH → IGF-I axis, meaning that stacking GH with LR3 could e…
**The antioxidant and anti-inflammatory profile of GHRP-2 does not automatically translate into structural plaque regression** — a critical distinction for anyone considering this peptide as a cardiovascular adjunct. …
**Finding GHRP-2 in commercially available nutritional supplements** means athletes and consumers may be unknowingly ingesting a non-approved peptide with systemic GH-releasing activity, creating both unintentional do…
**Clinicians and researchers** targeting age-related cardiovascular decline now have a cellular mechanism — EPC restoration via `IGF-1` — to anchor therapeutic protocols around GH secretagogues or direct IGF-1 interve…